Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides

Peritoneal Dialysis International

Volumn 27, Issue 1, 2007, Pages 86-89

  Alhamdani, Mohamed Saiel Saeed ^a   Al Azzawie, Hasan Fayadh ^b   Abbas, Fawzi K H ^a  

^a MUSTANSIRIYAH UNIVERSITY   (Iraq)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Advanced glycation end products (AGEs); Albumin; Aminoguanidine; Anserine; Carnosine; Collagen; Homocarnosine; Peritoneal fluid

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ANSERINE; CARNOSINE; COLLAGEN TYPE 4; DIALYSIS FLUID; GLUCOSE; HISTIDINE; HOMOCARNOSINE; HUMAN SERUM ALBUMIN; DRUG DERIVATIVE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; NITRIC OXIDE SYNTHASE;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; INCUBATION TIME; LONG TERM EXPOSURE; PERITONEAL DIALYSIS; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN ANALYSIS; SHORT COURSE THERAPY; SPECTROFLUOROMETRY; ASCITES FLUID; DRUG ANTAGONISM; DRUG EFFECT; FOLLOW UP; HUMAN; METABOLISM; TIME; UREMIA;

ANSERINE; ASCITIC FLUID; CARNOSINE; DIALYSIS SOLUTIONS; ENZYME INHIBITORS; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HISTIDINE; HUMANS; NITRIC OXIDE SYNTHASE; PERITONEAL DIALYSIS; SPECTROMETRY, FLUORESCENCE; TIME FACTORS; UREMIA;

EID: 33947167235     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700118     Document Type: Article

References (12)

1. Weiss MF. Pathogenic role of advanced glycation end-products (AGES): an overview. Perit Dial Int 1999; 19(Suppl 2): S47-52.
2. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, et al. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63:298-305.
3. Miyata T, van Ypersele de Strihou, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int 1999; 55:389-99.
4. Sakai A, Nakayama M, Numata M, Takesawa S, Nakamoto M. Sodium sulfite and N-acetylcysteine: new additives to dialysate for inhibiting formation of glucose degradation products and advanced glycation end-products. Adv Perit Dial 2001; 17:66-70.
5. Guiotto A, Calderan A, Ruzza P, Borin G. Carnosine and carnosine-related antioxidants: a review. Curr Med Chem 2005; 12:2293-315.
6. Hipkiss AR, Brownson C, Bertani MF, Ruiz E, Ferro A. Reaction of carnosine with aged proteins: another protective process? Ann N Y Acad Sci 2002; 959:285-94.
7. Hipkiss AR, Michaelis J, Syrris P. Non-enzymic glycosylation of the dipeptide L carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 1995; 371:81-5.
8. Price DL, Rhett PM, Thorpe SR, Baynes JW. Chelating activity of advanced glycation end-product inhibitors. J Biol Chem 2001; 276:48967-72.
9. Seidler NW, Yeargans GS, Morgan TG. Carnosine disaggregates glycated alpha-crystallin: an in vitro study. Arch Biochem Biophys 2004; 427:110-15.
10. Lamb EJ, Cattell WR, Dawnay AB. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1995; 47:1768-74.
11. Werynski A, Waniewski J, Wang T, Anderstam B, Lindholm B, Bergstrom J. Kinetic studies of dipeptide-based and amino acid-based peritoneal dialysis solutions. Kidney Int 2001; 59:363-71.
12. Bergstrom J, Furst P, Noree LO, Vinnars E. Intracellular free amino acids in muscle tissue of patients with chronic uraemia: effect of peritoneal dialysis and infusion of essential amino acids. Clin Sci Mol Med 1978; 54:51-60.